Clinical trial
Melanoma 4p: Biobanking and New Biomolecular Metrics
NCT05906277 is registered in ClinicalTrials.gov with Regina Elena Cancer Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Melanoma 4p: Biobanking and New Biomolecular Metrics
- Lead sponsor
- Regina Elena Cancer Institute
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- January 29, 2019
- Completion date
- December 31, 2025
- Enrollment
- 300 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
liquid biopsy, melanoma (skin)